Smith & Nephew SNATS Inc.

Smith & Nephew SNATS Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Smith & Nephew SNATS Inc. is not very popular among insiders. Smith & Nephew SNATS Inc. is a mediocre stock to choose.
Log in to see more information.
Smith & Nephew Plc engages in the development, manufacture, marketing, and sale of medical devices....
SNN Fundamental Data by TradingView

News

Cadence Welcomes Bob White to Board of Directors
Cadence Welcomes Bob White to Board of Directors

PR Newswire Cadence Welcomes Bob White to Board of Directors Cadence Welcomes Bob White to Board of Directors PR Newswire STAUNTON, Va., Sept. 12, 2024 STAUNTON, Va., Sept. 12, 2024 /PRNewswire/ -- Cadence...\n more…

3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications
3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications

Globe Newswire New TOTAL ANKLE Patient-Matched Guides pair with Smith+Nephew's Total Ankle replacement solution, designed to help surgeons save time and ensure accuracy while performing fewer steps than standard...\n more…

Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides

Globe Newswire Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to...\n more…

Allspring Global Investments Holdings LLC Grows Stock Position in Smith & Nephew plc (NYSE:SNN)
Allspring Global Investments Holdings LLC Grows Stock Position in Smith & Nephew plc (NYSE:SNN)

Ticker Report Allspring Global Investments Holdings LLC boosted its stake in shares of Smith Nephew plc (NYSE:SNN - Free Report) by 1,894.3% during the 2nd quarter, according to the company in its most...\n more…

One of my favourite FTSE 100 stocks is down 42%. But it's now making a rapid recovery
One of my favourite FTSE 100 stocks is down 42%. But it's now making a rapid recovery

The Motley Fool UK Medical technology company Smith & Nephews (LSE: SN.) one of my favourite FTSE 100 stocks. Currently, it's the fourth largest individual Footsie holding in my entire investment...\n more…

Smith & Nephew plc (NYSE:SNN) Receives Consensus Rating of "Moderate Buy" from Brokerages
Smith & Nephew plc (NYSE:SNN) Receives Consensus Rating of "Moderate Buy" from Brokerages

Zolmax Shares of Smith Nephew plc (NYSE:SNN - Get Free Report) have received an average recommendation of "Moderate Buy" from the six analysts that are currently covering the firm, MarketBeat...\n more…